Bizarre Patents
Process For Propelling Foodstuffs or the Like into a Crowd
A method of launching foodstuffs into a crowd for promotional and entertainment purposes.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7354905 | Prodrugs of thrombin inhibitors There is provided compounds of formula I, R1O(O)C—CH2—(R)Cgl-Aze-Pab-R2I wherein R1 and R2 have meanings given in the description, which are useful as prodrugs of inhibitors of trypsin-li... | 04/08/2008 |
| 7223745 | Proteasome inhibitors and methods of using the same The present invention provides boronic acid compounds, boronic esters, and compositions thereof that can modulate apoptosis such as by inhibition of proteasome activity. The compounds and compositions can be used in methods of inducing apoptosis and treating disease... | 05/29/2007 |
| 7135587 | Urea and urethane derivatives as integrin inhibitors Novel urea and urethane derivatives of general formula (I) in which R1, R2, R3, R5, R5′, X, Y, B, m, n and o are as defined in Patent Claim 1, and physiologically acceptable salts or solvates thereof are integrin inhibitors and can be employed for combating... | 11/14/2006 |
| 7015348 | Method for producing an optically active β-amino acid To provide a producing method of an optically active β-amino acid useful as intermediate for the production of medicines, agricultural chemicals and physiologically active substances, by means of a catalytic and asymmetric synthesis method of high performance and a... | 03/21/2006 |
| 6962905 | Pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug A kit of parts containing (a) a pharmaceutical formulation including a low molecular weight thrombin inhibitor, or a pharmaceutically acceptable derivative thereof, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, and (b) a pharmaceutica... | 11/08/2005 |
| 6960588 | Tryptase inhibitors Compounds of formula (I) in which M, B1, B2, B3, B4, B5, B6, A1, A2, A3, A4, A5, A6, K1 and K2 have the meanings as indicated in the description, are novel effective tryptase inhibitors. ... | 11/01/2005 |
| 6951946 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates Disclosed are efficient and scalable processes for preparing 1,2,4- and 1,3,4-oxadiazole carboxylates from readily available starting materials. ... | 10/04/2005 |
| 6946527 | Modified polymeric shaped body, method for producing the same and use thereof AGE precursors can be removed from blood, plasma or PBS buffer using a modified polymeric shaped body that can be produced by reaction of diaminoguanidine and/or triaminoguannidine with a staring polymeric shaped body carrying R—X residues, where R is an alkylene ... | 09/20/2005 |
| 6919449 | Process for the preparation of cephalosporin intermediate and its use for the manufacture of cephalosporin compounds The present invention relates to a method for the preparation of cephalosporin antibiotic of the formula (II), which comprises hydrolyzing and halogenating the ester of formula (III) by photochemical irradiation in one... | 07/19/2005 |
| 6888022 | Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or i... | 05/03/2005 |
| 6784311 | Method of producing 3-aminoalkanoic acid esters Process for the preparation of 3-aminoalkanoic acid esters of the general formula: in which R is C1-6-alkyl and R1 is hydrogen, C1-6-alkyl or phenyl, or their salts, by catalytic hydrogen... | 08/31/2004 |
| 6660246 | Ligands and metal complexes thereof Novel compounds of the formula ##STR1## and novel complexes of these compounds with metals are useful in diagnostic and therapeutic methods.... | 12/09/2003 |
| 6608196 | Process for solid supported synthesis of pyruvate-derived compounds Provided are processes for synthesizing structurally diverse pyruvate-derived compounds using a parallel approach on a solid phase support. Examples of such a solid phase support include resins which have also been used in solid phase peptide synthesis.... | 08/19/2003 |
| 6605688 | Low Viscosity imine reactive diluents and coating compositions made therefrom This invention concerns low viscosity aldimine and ketimine reactive diluents having multi-imine functionality, which are useful in automotive refinish coating compositions, including a process for making them and the coatings that contain them.... | 08/12/2003 |
| 6482974 | Process and intermediate compounds for the preparation of pyrrolidines Processes for the preparation of pyrrolidones (7 and 8) and pyrrolidines (9 and 10) from tri-O-acetyl-D-erythro-4-pentulosonic acid esters are described. The compounds are aza sugar analogs of D-ribofuranoside and are intermediates to drugs which regulate... | 11/19/2002 |
| 6482973 | Process and intermediate compounds for the preparation of pyrrolidines Processes for the preparation of pyrrolidones (7 and 8) and pyrrolidines (9 and 10) from tri-O-acetyl-D-erythro-4-pentulosonic acid esters are described. The compounds are aza sugar analogs of D-ribofuranoside and are intermediates to drugs which regulate... | 11/19/2002 |
| 6465686 | Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors The present invention discloses halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors.... | 10/15/2002 |
| 6420592 | Amino acid-derived phosponamidic anhydrides and methods of preparing the same Phosphonamide compounds and methods of forming those compounds are provided. The inventive methods comprise forming a template opened-ring phosphonamide compound and optionally subjecting the template to a ring-closing metathesis reaction in the presence ... | 07/16/2002 |
| 6365673 | Low viscosity imine reactive diluents and coating compositions made therefrom This invention concerns low viscosity aldimine and ketimine reactive diluents having multi-imine functionality, which are useful in automotive refinish coating compositions, including a process for making them and the coatings that contain them.... | 04/02/2002 |
| 6348617 | Method for purifying pyruvic acid compounds The present invention is directed to a method for purifying pyruvic acid compounds, which method comprises reacting a pyruvic acid compound of general formula (I): ##STR1## wherein R1 is an optionally substituted lower alkyl group, a lower ... | 02/19/2002 |
| 6187920 | Pyridazinone derivatives This invention provides pyridazinone derivatives encompassed by the following the formula: ##STR1## wherein, R1, R2, R3, R4, R5 and R7 represent a hydrogen atom and the like, and R6 | 02/13/2001 |
| 6130246 | Pesticides The compounds of formula I ##STR1## wherein: a) X is O, and Y is OC1 -C4 alkyl; or b) X is O or S, and Y is NHCH3 have fungicidal properties and can be used in plant protection for controlling and preventing disease infest... | 10/10/2000 |
| 6090974 | Alkyl 3-oxoalkanoate and process for the preparation thereof This invention includes an alkyl 3-oxoalkanoate, and processes for its preparation and use for the synthesis of fatty hydroxylated amino acids, fatty amino alcohols and ceramides.... | 07/18/2000 |
| 6034137 | Cationic lipids for gene therapy This invention provides novel cationic lipids, particularly guanidino lipids, and methods for their preparation. Also provided are polyanionic-lipid complexes comprising the lipids of the invention, their preparation and use to deliver biologically active... | 03/07/2000 |
| 5994577 | Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus The present invention provides novel compounds of the formula I and II for the treatment of non-insulin dependent diabetes mellitius (NIDDM) and a new use of known compounds for this purpose.... | 11/30/1999 |
| 5981511 | Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors The current invention discloses hydroxyamidino derivatives useful as nitric oxide synthase inhibitors.... | 11/09/1999 |
| 5977025 | 1,3-oxazin-4-one derivative, herbicide containing same, and intermediate for preparing same This invention provides 1,3-oxazin-4-one derivatives represented by following general formula (I): ##STR1## in which R1 represents a phenyl group which may be substituted; R2 represents a hydrogen atom or a lower alkyl group; R | 11/02/1999 |
| 5948931 | Preparation and use of -(hydroxyimino) phosphonoacetic acids -(hydroxyimino)phosphonoacetic acids (also referred to as ",-disubstituted trifunctional oximes" and "Troika Acids") and their derivatives, and methods to prepare them are disclosed. Also disclosed are the structures and fragmentation... | 09/07/1999 |
| 5945408 | Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors The current invention discloses hydroxyamidino derivatives useful as nitric oxide synthase inhibitors.... | 08/31/1999 |
| 5939392 | Method of thrombin inhibition The invention relates to new competitive tripeptide inhibitors of trypsin-like serine proteases, their synthesis, pharmaceutical compositions containing the compounds as active ingredients, and the use of the compounds as thrombin inhibitors, anticoagulan... | 08/17/1999 |
| 5935988 | Tolerability of pharmaceutically active ଲ-amino acids The present invention relates to mixtures of -amino acids and/or derivatives thereof and cyclopentane-ଲ-amino acids and/or derivatives thereof, dipeptides of the abovementioned -amino acids and cyclopentane-ଲ-amino acids and mixt... | 08/10/1999 |
| 5914319 | Antithrombotic agents This invention relates to thrombin inhibiting compounds having the Formula I X--Y--NH--(CH2)r --G I where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations contain... | 06/22/1999 |
| 5863931 | Amidino derivatives and their use as nitric oxide synthase inhibitors Amidino derivatives of formula (I) and salts, and pharmaceutically acceptable esters and amides thereof, in which: R1 is a C1-6 straight or branched chain alkyl group, a C2-6 alkenyl group, a C2-6 alkynyl group,... | 01/26/1999 |
| 5861533 | Process for nitrosation of C-H-acidic compounds A process for nitrosating C-H-acidic compounds. The process substantially avoids producing polluted wastewater.... | 01/19/1999 |
| 5847195 | Process for the production of compounds containing aspartate and aldimine groups The present invention relates to a process for preparing compounds containing aspartate and aldimine groups corresponding to the formula ##STR1## by a) reacting 50 to 95 mole % of the primary amino groups present in a polyamine containing 2 to 6 prim... | 12/08/1998 |
| 5726159 | Antithrombotic agents This invention relates to thrombin inhibiting compounds having the Formula I X--Y--NH--(CH2)r --G I where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations containi... | 03/10/1998 |
| 5710130 | Antithrombotic agents This invention relates to thrombin inhibiting compounds having the Formula I X--Y--NH--(CH2)r --G I where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations containi... | 01/20/1998 |
| 5710324 | Inhibitors of nitric oxide biosynthesis The present invention is directed to a new class of compound which are useful as inhibitors of the biosynthesis of nitric oxide.... | 01/20/1998 |
| 5707967 | Pain relief compositions Disclosed are compositions containing either aspartame or monosodium glutanate combined with an amino acid.... | 01/13/1998 |
| 5707966 | Antithrombotic agents This invention relates to thrombin inhibiting compounds having the Formula I X--Y--NH--(CH2)r --G I where X, Y, r and G have the values defined in the description, as well as pharmaceutical formulations containi... | 01/13/1998 |
